1. Chen, Haojie, Dong, Keqin, Ding, Jie, Cui, Xingang, Yu, Yongjiang. 2024. CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression. In Cancer letters, 587, 216725. doi:10.1016/j.canlet.2024.216725. https://pubmed.ncbi.nlm.nih.gov/38364963/
2. Sperger, Jamie M, Helzer, Kyle T, Stahlfeld, Charlotte N, Dehm, Scott M, Lang, Joshua M. . Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 29, 2324-2335. doi:10.1158/1078-0432.CCR-22-1305. https://pubmed.ncbi.nlm.nih.gov/36939530/
3. Oshikawa, Mio, Usami, Ron, Kato, Seishi. 2009. Characterization of the arylsulfatase I (ARSI) gene preferentially expressed in the human retinal pigment epithelium cell line ARPE-19. In Molecular vision, 15, 482-94. doi:. https://pubmed.ncbi.nlm.nih.gov/19262745/
4. Dariane, Charles, Timsit, Marc-Olivier. 2022. DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies. In European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 63, 155-164. doi:10.1159/000526415. https://pubmed.ncbi.nlm.nih.gov/35944490/
智鼠故事 
